By Elric Langton | 9 March 2022
Poolbeg Pharma (AIM: POLB), a clinical-stage infectious disease pharmaceutical company with a unique capital-light clinical model, announces its Annual Report and Accounts for the period ended 31 December 2021, and notice of the AGM is scheduled to be held at 11.00 am on 4 April 2022
Most of it is standard, but the Irish huβ¦